Subtopic Deep Dive

Phosphoethanolamine in Apoptosis Induction
Research Guide

What is Phosphoethanolamine in Apoptosis Induction?

Phosphoethanolamine is a synthetic phospholipid analog that induces apoptosis in cancer cells primarily via mitochondrial pathways and caspase activation.

Research focuses on its antiproliferative effects in breast cancer, leukemia, and hepatocellular carcinoma cells (Ferreira et al., 2013a; Ferreira et al., 2013b; Luna et al., 2018). Nine key papers from 2013-2023 document in vitro and in vivo antitumor activity, with the top three papers each garnering 46-58 citations. Mechanisms include cell cycle arrest and inhibition of angiogenesis and metastasis.

14
Curated Papers
3
Key Challenges

Why It Matters

Synthetic phosphoethanolamine (Pho-s) triggers mitochondrial apoptosis in MCF-7 breast cancer cells, offering potential to bypass chemotherapy resistance (Ferreira et al., 2013a, 58 citations). It shows in vivo anti-leukemia effects and reduces lung metastasis in models, positioning it as a candidate for novel cancer therapies (Ferreira et al., 2013b, 58 citations; Ferreira et al., 2013c, 46 citations). Liposomal formulations enhance cytotoxicity in hepatocellular carcinoma via intrinsic and extrinsic pathways (Luna et al., 2018, 11 citations).

Key Research Challenges

Clinical Translation Barriers

Limited human trials exist despite preclinical promise, as noted in surveys of Brazilian oncologists reporting unproven claims (Rêgo et al., 2017, 4 citations). Safety and efficacy data gaps hinder regulatory approval. Social media hype complicates objective assessment (Anastácio et al., 2018, 4 citations).

Mechanism Elucidation Gaps

Precise signaling pathways beyond mitochondrial involvement remain unclear in diverse cancers (Lorenzo et al., 2016, 5 citations). Variable responses across cell types challenge broad applicability (Luna et al., 2018, 11 citations). Theoretical models predict activity but lack experimental validation.

Formulation Optimization

Enhancing bioavailability requires liposomal delivery, as DODAC/Pho-s outperforms free Pho-s in hepatocellular models (Luna et al., 2018, 11 citations). Scalability and stability issues persist for clinical use. Inconsistent production quality affects reproducibility (Caetano et al., 2017, 2 citations).

Essential Papers

1.

Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway

Adilson Kleber Ferreira, Renato Meneguelo, Alexandre Pereira et al. · 2013 · Biomedicine & Pharmacotherapy · 58 citations

2.

Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine

Adilson Kleber Ferreira, Vanessa M. Freitas, Débora Levy et al. · 2013 · PLoS ONE · 58 citations

Taken together, our findings provide evidence that Pho-s is a compound that potently inhibits lung metastasis, suggesting that it is a promising novel candidate drug for future developments.

3.

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects

Adilson Kleber Ferreira, Bárbara A. Santana-Lemos, Eduardo Magalhães Rego et al. · 2013 · British Journal of Cancer · 46 citations

4.

Antiproliferative and proapoptotic effects of DODAC/synthetic phosphoethanolamine on hepatocellular carcinoma cells

Arthur Cássio de Lima Luna, Greice Kelle Viegas Saraiva, Gilberto Orivaldo Chierice et al. · 2018 · BMC Pharmacology and Toxicology · 11 citations

The overall results showed that DODAC/PHO-S liposomes were more effective than PHO-S alone, in promoting cytotoxicity Hepa1c1c7 tumor cells, activating the intrinsic and extrinsic pathways of progr...

5.

Theoretical Study of Phosphoethanolamine: A Synthetic Anticancer Agent with Broad Antitumor Activity

Vitor Prates Lorenzo, Francisco Jaime Bezerra Mendonça, José Maria Barbosa‐Filho et al. · 2016 · Journal of Chemistry · 5 citations

Cancer is a major public health problem with limited success of available treatments, pointing to the need for new strategies to be developed. Phosphoethanolamine exhibits broad antitumor activity ...

6.

Synthetic phosphoethanolamine: the state of the art of scientific production

Lucas de Barros Anastácio, Camila Rocha Delmaschio, Danielle A. G. Cavalcanti Oliveira et al. · 2018 · Brazilian Journal of Pharmaceutical Sciences · 4 citations

ABSTRACT Cancer is a multifactorial disease and a serious public health problem. Currently, alternative drug treatments for cancer are actively being sought, which is the case of synthetic phosphoe...

7.

A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamine

Juliana Florinda M. Rêgo, Gilberto Lopes, Rachel P. Riechelmann et al. · 2017 · Revista da Associação Médica Brasileira · 4 citations

Summary Introduction: Patients who are treating cancer have often used alternative therapies. In the internet era, information can be broadcasted widely, and this happened with phosphoethanolamine ...

Reading Guide

Foundational Papers

Start with Ferreira et al. (2013a, 58 citations) for mitochondrial apoptosis in breast cancer and Ferreira et al. (2013b, 58 citations) for anti-metastatic activity, as they establish core mechanisms cited across subtopic.

Recent Advances

Study Luna et al. (2018, 11 citations) for liposomal improvements and Rossini (2023) for critical biological effects analysis.

Core Methods

Core techniques include MTT assays for cytotoxicity, flow cytometry for apoptosis, Western blots for caspases, and xenograft models for in vivo validation (Ferreira et al., 2013a/c; Luna et al., 2018).

How PapersFlow Helps You Research Phosphoethanolamine in Apoptosis Induction

Discover & Search

Research Agent uses searchPapers and citationGraph to map Ferreira et al. (2013a, 58 citations) as the hub connecting breast cancer apoptosis to anti-leukemia effects (Ferreira et al., 2013c). exaSearch uncovers related works like Luna et al. (2018) on liposomal enhancements; findSimilarPapers expands to 50+ phosphoethanolamine studies.

Analyze & Verify

Analysis Agent applies readPaperContent to extract caspase activation data from Ferreira et al. (2013a), then verifyResponse with CoVe checks claims against abstracts. runPythonAnalysis plots dose-response curves from extracted metrics using pandas/matplotlib; GRADE grading scores evidence as moderate for preclinical apoptosis induction.

Synthesize & Write

Synthesis Agent detects gaps in clinical data via contradiction flagging across Rêgo et al. (2017) and Ferreira papers, generating exportMermaid diagrams of mitochondrial pathways. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10 papers, with latexCompile producing polished manuscripts.

Use Cases

"Plot apoptosis rates from phosphoethanolamine papers using Python."

Research Agent → searchPapers (Ferreira 2013 papers) → Analysis Agent → readPaperContent (extract IC50 data) → runPythonAnalysis (pandas plot dose-response curves) → matplotlib figure of cell death kinetics.

"Write LaTeX review on Pho-s mitochondrial pathway."

Synthesis Agent → gap detection (Ferreira et al. 2013a/b) → Writing Agent → latexEditText (pathway section) → latexSyncCitations (9 papers) → latexCompile (PDF with pathway diagram).

"Find code for Pho-s molecular dynamics simulations."

Research Agent → paperExtractUrls (Lorenzo et al. 2016) → Code Discovery → paperFindGithubRepo (quantum chem sims) → githubRepoInspect (DFT scripts for phosphoethanolamine binding energies).

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers (Pho-s + apoptosis) → citationGraph (Ferreira cluster, 200+ cites) → structured report ranking 2013 papers. DeepScan applies 7-step analysis with CoVe checkpoints on Luna et al. (2018) liposome data, verifying proapoptotic claims. Theorizer generates hypotheses linking Pho-s to chemotherapy sensitization from 10-paper synthesis.

Frequently Asked Questions

What is phosphoethanolamine's primary apoptosis mechanism?

It induces cell cycle arrest and mitochondrial pathway apoptosis in MCF-7 breast cancer cells (Ferreira et al., 2013a, 58 citations).

What are key methods in Pho-s research?

In vitro assays measure caspase activation and Annexin V staining; in vivo models assess tumor growth and metastasis (Ferreira et al., 2013b, 58 citations; Luna et al., 2018, 11 citations).

Which papers have highest citations?

Ferreira et al. (2013a) and (2013b) each have 58 citations on breast cancer and anti-metastatic effects; Ferreira et al. (2013c) has 46 on leukemia (all 2013).

What open problems exist?

Clinical trials are absent; mechanism details in non-breast cancers need clarification; optimized formulations for human use remain undeveloped (Rêgo et al., 2017; Rossini, 2023).

Research Biological Research and Disease Studies with AI

PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:

See how researchers in Life Sciences use PapersFlow

Field-specific workflows, example queries, and use cases.

Life Sciences Guide

Start Researching Phosphoethanolamine in Apoptosis Induction with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers